Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Wall Street set for weak open on hedge fund-retail battle

Fri, 29th Jan 2021 12:22

* U.S. futures, European stocks drop 0.5-0.8%

* Dollar index eyes weekly gain

* GameStop price nearly doubles in U.S. pre-market

* Bitcoin jumps 14% after Elon Musk mention

By Carolyn Cohn

LONDON, Jan 29 (Reuters) - U.S. stock futures and European
stocks fell on Friday while the safe-haven dollar held its
ground as a Wall Street battle between hedge funds and retail
investors and a row in Europe over COVID-19 vaccine supply
cooled risk appetite.

Wall Street has been gripped by an assault by small traders
organising over online forums, such as Reddit, to force hedge
funds to reverse short positions - or bets that stocks would
fall - on companies such as GameStop and AMC
Entertainment.

The stand-off comes after central bank and government
stimulus have propelled stock markets to record highs in recent
weeks, encouraging involvement by retail investors.

"There's fear in terms of the volatility," said Derek
Halpenny, head of research for global markets at MUFG. "Specific
trades in pockets of the market can spread into the broader
market."

Shares in GameStop, AMC Entertainment and
BlackBerry plunged more than 40% on Thursday after
several online platforms imposed buying halts, but rebounded as
Robinhood and Interactive Brokers eased the restrictions on
Friday.

GameStop shares nearly doubled and AMC Entertainment was up
55% in U.S. pre-market trade.

"Any hedge fund will be carefully looking at all their
shorts after this week and regulators will look very carefully
at collective retail trading," Deutsche Bank analysts said.

S&P 500 futures recouped some ground in European
trade but were down 0.5% by 1138 GMT. Nasdaq 100 futures
fell 0.7% .

Britain's FTSE 100 index fell 0.8% and European
stocks dropped 0.7%.

VACCINE ROW

Delays in COVID-19 vaccine production have snowballed into a
spat between Britain, the European Union and drugmakers over how
best to direct limited supplies.

AstraZeneca offered eight million more doses of its
COVID-19 vaccine to the European Union, after it unexpectedly
announced cuts in supplies last week. But the bloc said that was
far short of what was originally promised, an EU official told
Reuters on Friday.

New variants of the novel coronavirus have also prolonged
lockdowns and delayed expectations of an economic rebound.

Barclays analysts, however, said that "institutional
positioning is not aggressive overall, and as long as vaccines
work and central banks stay put, buy-the-dip mentality should
continue".

Click here http://tmsnrt.rs/2EmTD6j for an interactive chart
on the vaccine race

The U.S. dollar rose to its highest since mid-November
against the yen, and was steady against an index of
currencies, bringing its weekly rise to 0.4%. The euro
edged up 0.1% and the pound was steady.

Bitcoin jumped as much as 14% to a two-week high
after Tesla Inc TSLA.O chief Elon Musk tagged the cryptocurrency
in his Twitter biography.

French 10-year government bond yields, which
move inversely to price, rose four basis points after France's
gross domestic product contracted less than expected in the
fourth quarter of 2020.

World stocks fell 0.4% towards three-week
lows set in the previous session, and were heading for a weekly
fall of more than 2%.

MSCI's broadest index of Asia-Pacific shares outside Japan
fell 1%, on course for a weekly loss of 4.4%.
Japan's Nikkei fell 1.9%, recording its first weekly
loss of the year.

The People's Bank of China (PBOC) injected 100 billion yuan
into the financial system on Friday, following a week of
reducing liquidity, which had sparked concerns the central bank
was in fact tightening monetary policy.

The extra money did little to loosen short-term money
markets, where rates rose for a fifth straight day and benchmark
overnight repo rates surged to their highest in
nearly six years.

Oil prices rose within recent ranges, with concerns caused
by the new coronavirus variants and slow vaccine rollouts
offsetting a cut in Saudi Arabian oil supply and falling U.S.
oil inventories.

Brent crude futures were up 0.88% at $56.02 a barrel
and U.S. crude futures rose 0.5% to $52.60 a barrel.

Gold benefited from demand for safer assets, rising
1.1%.

(Additional reporting by Tom Westbrook in Singapore and Alwyn
Scott in New York; Editing by Richard Pullin, Ana Nicolaci da
Costa, William Maclean, Larry King)

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.